| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 5.77 Million |
| Market Size (2030) | USD 8.07 Million |
| CAGR (2025 - 2030) | 6.93 % |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Algeria And Morocco Electrocardiograph (ECG) Market Analysis
The Algeria And Morocco Electrocardiograph Market size is estimated at USD 5.77 million in 2025, and is expected to reach USD 8.07 million by 2030, at a CAGR of 6.93% during the forecast period (2025-2030).
The increasing prevalence of cardiovascular diseases and advancements in healthcare infrastructure drives the electrocardiogram (ECG) market in Algeria and Morocco. ECG devices are critical in diagnosing and monitoring heart-related conditions, making them indispensable in the healthcare systems of these countries. The growing burden of lifestyle-related diseases, coupled with the rising geriatric population, is further propelling the demand for ECG devices. Both Algeria and Morocco are focusing on improving healthcare accessibility and investing in advanced medical technologies, which is expected to create substantial opportunities for the ECG market during the forecast period.
The substantial burden of cardiovascular diseases in Algeria and Morocco drives the demand for diagnostic devices such as the ECG machine. For instance, a report published by the United Nations Population Fund (UNFPA) in January 2024 highlighted that in Morocco, 11.7% of females aged 60-79 and 11.8% of those aged 80 and above had cardiovascular diseases in 2023. Similarly, 9.7% of males aged 60-79 and 11.6% of those aged 80 and above were affected by cardiovascular diseases. These statistics underscore the growing need for effective diagnostic tools like ECG devices to manage and monitor cardiovascular conditions, thereby boosting market growth.
Additionally, lifestyle-related diseases such as diabetes, obesity, and hypertension are on the rise in Algeria, further driving the demand for ECG devices. For instance, a study published in Population Medicine in June 2024 revealed that over 15 years, the prevalence of type 2 diabetes increased from 6% to 12%, obesity rose from 16% to 24%, and hypertension surged from 26% to 44%, depending on the region of Algeria. These conditions are closely linked to cardiovascular health, necessitating the use of ECG devices for early detection and management, which is expected to impact the market positively.
Furthermore, significant investments in healthcare infrastructure are contributing to the growth of the ECG market in Morocco. For instance, in May 2024, the Mohammed VI International University Hospital project, set to be constructed in Rabat, Morocco, represents a significant development. Scheduled for completion, this EUR 450 million (USD 489 million) project will feature a 33-floor facility, including a medical technology cluster, a conference room, and a national league dedicated to cardiovascular diseases. Such initiatives are expected to enhance the adoption of advanced ECG technologies, further driving market growth.
Thus, the ECG market in Algeria and Morocco is poised to grow over the forecast period driven by the significant prevalence of cardiovascular and lifestyle-related diseases, coupled with substantial investments in healthcare infrastructure. However, the high cost associated with advanced ECG devices may act as a barrier, potentially limiting the market's expansion in the country during the same period.
Algeria And Morocco Electrocardiograph (ECG) Market Trends
Holter ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
Holter ECG systems are portable devices designed to continuously record the heart's electrical activity over extended periods, typically ranging from 24 to 48 hours or longer. The systems are particularly effective in diagnosing arrhythmias and other cardiac conditions that may not be detected during standard electrocardiograms (ECGs) conducted in clinical settings.
Due to the high prevalence of cardiovascular diseases in Algeria and Morocco, the adoption of Holter ECG systems is gaining momentum, driven by the need for accurate and continuous cardiac monitoring. For instance, a study published in the Egyptian Heart Journal in January 2024 revealed that nearly one million Moroccans suffer from heart failure annually, with this number expected to rise in the coming years. This growing prevalence underscores the need for advanced diagnostic tools like Holter ECG systems to enable early detection and effective management of cardiac conditions.
Furthermore, the trend of seeking medical treatment abroad, particularly for cardiovascular conditions, highlights the gaps in local healthcare infrastructure and the potential for market growth. For instance, according to a study published in the International Journal of Surgery in June 2024, over half a million Algerians annually seek medical treatment abroad, with a significant proportion being cardiovascular patients. This trend indicates an unmet demand for advanced cardiac care solutions, including Holter ECG systems, within the domestic market.
Moreover, investments in healthcare infrastructure are further propelling the adoption of Holter ECG systems in Algeria. In March 2024, a delegation of United States and Algerian representatives celebrated the successful delivery and installation of upgraded field hospital facilities in Blida. These new facilities aim to enhance emergency healthcare services and expand local capacity to address medical exigencies. Such developments reflect a growing focus on improving healthcare delivery, which is likely to drive the demand for advanced diagnostic equipment, including Holter ECG systems.
Therefore, the Holter ECG system segment, is poised for significant growth due to the rising prevalence of cardiovascular diseases, increasing medical tourism, and ongoing investments in healthcare infrastructure.
Understand The Key Trends Shaping This Market
Download PDF
Increasing Geriatric Population and Obesity Burden Contributes to the Market Growth
Electrocardiogram (ECG) devices play a critical role in diagnosing and monitoring heart-related conditions, making them an essential component of the healthcare infrastructure in these countries. The growing burden of lifestyle-related diseases, coupled with an aging population, is further propelling the demand for ECG devices in the region.
Older adults are more susceptible to cardiovascular diseases, necessitating frequent monitoring and diagnosis. For instance, according to the 2023 Atlas of Cardiovascular Disease Statistics, females aged above 65 years accounted for 6.6% of Algeria's population and 7.9% of Morocco's population in 2023. This demographic trend underscores the growing need for ECG devices to cater to the healthcare requirements of the aging population in these countries.
Additionally, the increasing prevalence of obesity and related risk factors, such as diabetes and hypertension, is significantly impacting the demand for ECG devices in Algeria and Morocco. For instance, in September 2024, a study published in BMC Public Health highlighted the significant burden of cardiovascular disease (CVD) risk factors among women in Morocco. The research emphasized a notable prevalence of diabetes, obesity, and hypertension. In 2023, the study reported that obesity rates among urban women aged 35 and older ranged between 14% and 44.9%. Diabetes rates, notably higher among menopausal women, ranged from 7.2% to 12.6%. Additionally, the prevalence of hypertension was observed to be between 29.8% and 39.29% during the same year. Thus, these conditions are major contributors to cardiovascular diseases, driving the need for effective diagnostic tools like ECG devices. The prevalence of these risk factors is notably higher in older age groups, further emphasizing the importance of ECG devices in managing and diagnosing heart-related conditions.
Therefore, the demand for advanced diagnostic tools, such as ECG devices, is expected to grow as healthcare systems in these countries strive to address the challenges posed by an aging population and the prevalence of lifestyle-related diseases. These factors, combined with advancements in healthcare technology, are likely to shape the future of the ECG market in Algeria and Morocco, making it a critical component of the region's healthcare landscape.
Get Analysis on Important Geographic Markets
Download PDF
Algeria And Morocco Electrocardiograph (ECG) Industry Overview
The competitive landscape of the electrocardiograph (ECG) market in Algeria and Morocco is characterized by a mix of established companies and emerging players. The market is consolidated yet dynamically competitive. Additionally, many companies offer specialized solutions, contributing to a vibrant and evolving ecosystem. Some of the major players in the market include Koninklijke Philips N.V., SCHILLER AG, Bionet Co., Ltd., Nihon Kohden Corporation, and Avecinna Company, among others.
Algeria And Morocco Electrocardiograph (ECG) Market Leaders
-
GE HealthCare
-
SCHILLER
-
Nihon Kohden Corporation
-
Bionet Co., Ltd.
-
Avecinna Company
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Algeria And Morocco Electrocardiograph (ECG) Market News
- January 2025: Morocco's Minister of Health and Social Protection, Amine Tahraoui, revealed that between 2023 and 2024, several new healthcare facilities were inaugurated, while others underwent renovations or expansions, collectively adding over 2,100 hospital beds. Notable projects encompass the construction and equipping of the Tangier University Hospital Center, which has 797 beds, the Regional Hospital Center in Kenitra, which has 450 beds, and the Regional Hospital Center in Al Hoceima, which has 250 beds.
- March 2024: Eni, which focused on health and education, launched a project to strengthen health facilities in Algeria's remote Haut-Plateau and southern regions. In Algiers, the Eni Foundation introduced two mobile clinics. In collaboration with the Algerian Ministry of Health, Population, and Hospital Reform, the Eni Foundation worked to improve health services in Algeria's underserved areas.
Algeria And Morocco Electrocardiograph (ECG) Industry Segmentation
As per the scope of the report, an electrocardiograph (ECG) is a medical device used to record the heart's electrical activity. The device captures the heart's electrical signals and produces a graphical representation known as an electrocardiogram.
The Algeria and Morocco electrocardiograph (ECG) market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The Algeria and Morocco ECG market is segmented by product type, which includes resting (12-lead ECG) systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
| By Product Type | Resting (12-Lead ECG) Systems |
| Stress ECG Systems | |
| Holter ECG Systems | |
| ECG Management Software | |
| By Country | Algeria |
| Morocco |
Need A Different Region or Segment?
Customize Now
Algeria And Morocco Electrocardiograph (ECG) Market Research FAQs
How big is the Algeria And Morocco Electrocardiograph Market?
The Algeria And Morocco Electrocardiograph Market size is expected to reach USD 5.77 million in 2025 and grow at a CAGR of 6.93% to reach USD 8.07 million by 2030.
What is the current Algeria And Morocco Electrocardiograph Market size?
In 2025, the Algeria And Morocco Electrocardiograph Market size is expected to reach USD 5.77 million.
Who are the key players in Algeria And Morocco Electrocardiograph Market?
GE HealthCare, SCHILLER, Nihon Kohden Corporation, Bionet Co., Ltd. and Avecinna Company are the major companies operating in the Algeria And Morocco Electrocardiograph Market.
What years does this Algeria And Morocco Electrocardiograph Market cover, and what was the market size in 2024?
In 2024, the Algeria And Morocco Electrocardiograph Market size was estimated at USD 5.37 million. The report covers the Algeria And Morocco Electrocardiograph Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Algeria And Morocco Electrocardiograph Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Algeria And Morocco Electrocardiograph (ECG) Industry Report
Statistics for the 2025 Algeria And Morocco Electrocardiograph (ECG) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Algeria And Morocco Electrocardiograph (ECG) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
